A number of pregnant women all over the world suffer from depression and are treated during gestation with antidepressants, mostly with selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors. Exposure to prenatal stress is also a great risk factor for a developing fetus and could be responsible for altered fetal development or various neurobehavioral disturbances of a child. Administration of selective serotonin and norepinephrine reuptake inhibitor venlafaxine is associated with various cardiovascular adverse effects, such as tachycardia, increased blood pressure, arrhythmias and hypertensive crisis. The aim of this study was to focus on the effect of pre-gestational chronic mild unpredictable stress and/or administration of antidepressant venlafaxine (10 mg/kg/day, p. o.) on specific parameters, determining the function of the cardiovascular system of male and female rat offspring. Blood pressure and standard ECG were recorded in the offspring. Exposure to pre-gestational stress did not cause significant changes in the systolic, diastolic blood pressure and pulse frequency either in males or in females, compared to the unexposed control animals. Pre-gestational stress caused the shortening of QT interval and prolongation of QRS complex duration in males. On the other hand, in females, the effects of pre-gestational stress were potentiated by the administration of venlafaxine and resulted in elevated systolic and diastolic blood pressure, prolonged QT interval and shortened QRS complex duration, compared to the control. In conclusion, the female rat offspring are more sensitive to exposure to pre-gestational, to chronic mild unpredictable stress and venlafaxine. Effect of pre-gestational stress and prenatal venlafaxine administration on cardiovascular system... Eur. Pharm. J. 2018, 65 (2): 17-22. 
Depression is a stress-related, affective disorder, with prevalence of 10-18% among pregnant women all over the world. Exposure to prenatal stress represents a great risk factor for developing pregnancy diseases (preeclampsia, miscarriages, gestational hypertension and hypoxia of the fetus), altered fetal development, low birth weight and a range of neurobehavioral disturbances of a child, including autism, anxiety and depression (St-Pierre et al., 2016; Kiryanova et al., 2017; Gemmel et al., 2018) . During gestation, 2-3% women are treated with antidepressants (AD), mostly with selective serotonin reuptake inhibitors (SSRI) or selective serotonin and norepinephrine reuptake inhibitors (SNRI). These substances act by blocking the serotonin transporter (5-HTT) and increasing the extracellular level of serotonin (Hanley & Oberlander, 2013) . Being relatively small molecules, SSRIs/ SNRIs cross the placenta and are able to affect the fetal serum levels of serotonin (Kim et al., 2006) . Prenatal exposure to SSRIs is connected with an increased risk of neonatal AD withdrawal syndrome, neurobehavioral alterations, persisting pulmonary hypertension, low birth weight and cardiovascular abnormalities (Chambers et al., 1996; Kallen, 2004 Furu et al. (2015) , the most frequent adverse effects of AD are cardiovascular defects, however, the mechanism of these defects is still unclear. Venlafaxine belongs to the group of SNRIs and acts by the inhibition of both serotonin and norepinephrine reuptake (Kivrak et al., 2014) and has been used for depression therapy since 1994. Venlafaxine administration is associated mostly with mild adverse effects, such as tachycardia, increased blood pressure (BP), arrhythmias, headache, dizziness, dry mouth and is also reported as a cause of hypertensive crisis (Khurana & Baudendistel, 2003; Ciuna et al., 2004; Johnson et al., 2006; Howell et al., 2007) . Premedication of rats with venlafaxine in a single dose 30 mg/kg, 24 hours before isolation of the heart and perfusion according to Langendorff, caused significantly increased incidence of ventricular tachycardia and QTc interval prolongation in spontaneously beating isolated heart (Vicen et al., 2016). Administration of venlafaxine in pregnancy affects both maternal and fetal levels of serotonin. Serotonin, a neurotransmitter involved in brain and heart development, is also involved in the functional regulation of cardiovascular system (CVS), including vasoconstriction, cardiomyocyte apoptosis, incidence of arrhythmias, such as tachycardia (Gregs et al., 2009 (Kiryanova et al., 2017) . To our knowledge, there have not been studies examining the simultaneous exposure to prenatal stress and SNRIs. Therefore, the purpose of our study is the analysis of the effect of pre-gestational chronic mild unpredictable stress and/or administration of antidepressant venlafaxine on the function of CVS of rat offspring of both genders.
matErIal and mEthodS

Animals
The experiments were conducted in compliance with the Principles of Laboratory Animal Care issued by the Ethical Committee of the Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine (CEM), Slovak Academy of Sciences, Bratislava, and the experimental design was approved by the State Veterinary and Food Administration of the Slovak Republic (Protocol No.: 1030/16/221). In this study, the female Wistar rats were obtained from the Department of Toxicology and Laboratory Animal Breeding Station of Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine, Slovak Academy of Sciences, Dobra Voda, Slovakia. Rats had free access to standard rat chow and water and were kept in a room with controlled temperature (20-24 °C) , and relative humidity (50-60%), with 12/12 hour light/dark cycle. Half the number of the animals (age: 3 months, n = 30) were exposed to chronic mild unpredictable stress for 2 weeks in total. Animals were exposed 2 times per day to following stressors: 1. Overcrowding (6 rats in 1 cage for 24 h), 2. Damp bedding (8 h, 500 ml of tap water), 3. Food deprivation (12 h), 4. Rotation of the cage (cages were reversed front to back once in 12 h), 5. Water deprivation (5 h), 6. Decline of the cage (45 degree, 12 h), 7. Swim stress (vertical cylindrical glass container -45 cm high, Ø 25 cm, filled with tap water at temperature 26 ± 1 °C). Stressors were picked up randomly and animals were exposed to 2 different stressors each day . Three weeks after the stress conditions females were mated with age-matched males in the ratio 1 male : 3 females. Day 0 of gestation was determined by the presence of sperms in vaginal smears. Pregnant rats were housed in plastic cages, 3 per cage. On the 15th day of gestation, the females were separated and housed individually. Vehicle or venlafaxine (10 mg/kg/day, Chemos, Regenstauf, Germany) were applied twice a day per os (on biscuits) to dams that were divided into the following groups: non-stress + vehiculum, nonstress + venlafaxine, stress + vehiculum, stress + venlafaxine. Venlafaxine was administered to dams for 74 days in total. Offspring were separated from their mothers on the 21st day postpartum and divided, according to their exposure to pregestational stress or prenatal venlafaxine administration and according to gender, into the following groups: non-stress + vehiculum male (NSKM, n = 5), non-stress + venlafaxine male (NSVM, n = 5), stress + vehiculum male (SKM, n = 5), stress + venlafaxine male (SVM, n = 5), non-stress + vehiculum female (NSKF, n = 6), non-stress + venlafaxine (NSVF, n = 6), stress + vehiculum female (SKF, n = 6), stress + venlafaxine female (SVF, n = 6).
Blood pressure and ECG measurement
The experiments were realized in offsprings´ in "in vivo" conditions, while the age of the offspring was between 110-120 days. Blood pressure (BP) was measured in unanaesthetized rats using non-invasive tail cuff method. Animals were prewarmed at 37 °C for 10 min and BP was measured at the dorsolateral tail artery by tail cuff MLT125R Cuff & Transducer, using NIBP Controller (ADInstruments, Spechbach, Germany) and Powerlab 8/30 (ADInstruments, Spechbach, Germany) (Fig. 1) . Consequently, the standard ECG was monitored in animals using Seiva EKG Praktik Veterinary (Seiva s.r.o., Prague, Czech Republic) (Kráľová et al., 2008). Stored recordings were statistically analyzed in Excel (Microsoft Excel, Version 15.40) and all the data are presented as mean ± SEM; for statistical comparison between the groups, the Student's t-test was used. After the functional measurements, the hearts were excised under general anesthesia. (Fig. 2a) showed that exposure to pregestational stress modified systolic and diastolic BP in both males and females. Venlafaxine alone caused either nonsignificant decrease in systolic and diastolic BP in males, and non-significant increase in females. Pre-gestational stress potentiated the effect of venlafaxine (SV group) in females and manifested as a significant increase in systolic and diastolic BP compared to SKF group. In both genders, pregestational stress induced a non-significant increase of pulse frequency (PF) compared to control (males: NSKM -339.76 ± 2.94 beats/min, SKM -343.09 ± 6.8 beats/min; females: NSKF -350.01 ± 4.80 beats/min, SKF -373.62 ± 8.56 beats/min). Administration of venlafaxine to dams exposed to stress did not induce changes in PF of their offsprings. Standard ECG recordings analysis from anesthetized rats, was focused on the selected parameters, like QT interval and QRS complex duration and showed changes in cardiac electrical activity induced by exposure to pre-gestational chronic unpredictable mild stress or prenatal administration of venlafaxine (Fig 2b) . In males, the exposure to pre-gestational stress led to nonsignificant shortening of QT interval compared to nonstressed control. Venlafaxine alone did not affect the duration of QT interval, but was able to suppress the effect of pregestational stress. QRS complex was significantly prolonged by 64% in male rats prenatally exposed to venlafaxine (NSVM) compared to the control (NSKM) (NSKM -14.48 ± 0.97 ms; NSVM -23.8 ± 0,71 ms, respectively). Stress combined with venlafaxine (SVM) did not cause further prolongation of QRS complex duration, however, mild shortening was found. In females, the duration of QT interval was not affected by exposure to pre-gestational stress. Prenatal administration of venlafaxine induced non-significant prolongation of QT interval in females not exposed to pre-gestational stress and this effect was augmented by stress, as this change was significant (SKF -54.8 ±0.78 ms; SVF -61.44 ± 2.66). We did not observe changes in QRS complex duration induced by stress or venlafaxine, but their combination led to significant shortening compared to control (SKF -21.64 ± 0.74 ms; SVF -16.04 ± 1.86 ms). After functional measurements, the hearts were excised under general anesthesia and weighed. The body weight of males and females, 355.95 ± 5.65 g, 216.28 ± 3.46 g, respectively, was not affected either by stress or by venlafaxine separately. Heart weight decreased after prenatal exposure to venlafaxine in the male and female venlafaxine groups. Significant decrease in heart weight was observed in the male venlafaxine group NSVM (1.021 ± 0.056 g) compared to the control NSKM group (1.224 ± 0.054 g) and also in the female venlafaxine group SVF (0.761 ± 0.031 g) compared to control SKF group (0.841 ± 0.025 g).
rESultS
Analysis of BP
dIScuSSIon
Exposure to pre-gestational stress did not cause significant changes in systolic, diastolic BP and PF either in males or in females, compared to the unexposed animals. Disturbances in cardiac electrical activity caused by pre-gestational stress 
elypsis). After reaching the maximum amplitude, we can find a small decrease, which represents a value of diastolic BP (dBP, small black curves above and below the spindle). The middle blue curve represents pressure changes in the cuff and on the lower green track, the pulse frequency of the rat is seen (modified according to Vicen, 2016).
were reflected as non-significant shortening of QT interval and prolongation of QRS complex duration in males, but not in females. On the other hand, in females, the effects of pre-gestational stress were aggravated by administration of venlafaxine and resulted in elevated systolic and diastolic BP, prolonged QT interval and shortened QRS complex duration. In general, venlafaxine showed potential to worsen rather than improve mild effects of pre-gestational stress on CVS of rat offspring, probably related to lower heart weight. Both stress and venlafaxine are known to affect the function of CVS, but in spite of that, their common effects during pregnancy and the impact on the fetus and the adult offspring is not properly described. We focused on the effects of pre-gestational stress and prenatal administration of venlafaxine on BP and selected ECG parameters in both genders monitored in "in vivo" conditions. Our study showed that differences in blood pressure due to pre-gestational stress and/or prenatal venlafaxine administration were more evident in the females. Venlafaxine alone had a tendency to increase systolic and diastolic BP. This effect was potentiated by stress and could be characterized as a pre-hypertension. Some studies (Capello et al., 2011; Bourke et al., 2013) showed, that chronic mild unpredictable stress during gestation leads to chronic activation of hypothalamic-pituitary-adrenal (HPA) axis because of increased basal plasma corticosterone levels in offspring. According to Szuran et al. (2000) , plasma levels of corticosterone were higher only in females, not males, after prenatal exposure to stress. Venlafaxine administration is known to have a dose-dependent hypertensive effect (Feighner, 1995) , and similarly, the other AD from the group of SSRIs could lead to gestational hypertension (Toh et al., 2009 ). Mild electrophysiological disturbances were observed in the duration of QT interval and QRS complex. Prolongation of QT interval was more evident in females. Venlafaxine alone was able to non-significantly prolong the QT interval, and this change was potentiated by pre-gestational stress. We also found venlafaxine-induced prolongation of QRS complex duration in males and, by contrast, shortening of QRS complex in females in combination of pre-gestational stress and venlafaxine. In experimental and clinical practice, the usage of venlafaxine was previously connected with QT interval prolongation (Bavle, 2015; Vicen et al., 2016) , but this effect was never studied in children or adults prenatally exposed to venlafaxine. Sari & Zhou (2003) presented, that prenatal administration of SSRIs can affect the heart development, by decreasing of proliferation of cardiomyocytes and, in a lower rate, also non-muscular cardiac cells. Therefore, prenatal exposure to SSRIs and possibly SNRIs may lead to conduction changes in the heart of offspring, demonstrated as changes in selected ECG parameters. Biometrical analysis showed that pre-gestational stress and venlafaxine caused a decrease in the heart weight of male and female offspring. As the venlafaxine belongs to the group of SNRIs, it affects the levels of serotonin in the mother and her unborn child. Serotonin is a neurotransmitter involved in heart development; therefore, serotonergic manipulation could induce morphological changes through two mechanisms: damage of heart cells (reduction of proliferation, not apoptosis) and reduction in their size (insufficient growth in postnatal development). Experiments with mice lacking serotonin 5-HT 2B receptor, that is expressed in embryotic and adult heart, showed that this receptor is required for cardiovascular regulation. 5-HT 2B receptor mutant mice suffered from gross heart deficit, while the CNS was not evidently affected (Nebigil et al., 2000; Nebigil et al., 2001 ). Toscano et al. (2008) found lower heart weight compared to control, due to a decrease in myocyte size, after fluoxetine treatment (SSRI).
In conclusion, the exposure to pre-gestational chronic mild unpredictable stress and/or prenatal venlafaxine administration lead to changes in the cardiovascular system of rat offspring of both genders. Even though these changes are mild, still they are statistically significant and represent evidence that more experiments are needed to confirm the safety or risk of venlafaxine use in pregnancy. This study brings the original results, transferring the characteristic of animal depression-like status of mother induced by repeated stress conditions to simulate the maternal depression observed in clinical practice and the effect on the children in early and later life.
acKnoWlEdGEmEntS
Our immense gratitude belongs to the director of the Centre of Experimental Medicine and Institute of Experimental Pharmacology SAS, RNDr. Michal Dubovický, CSc., for enabling this cooperation and realization the measurements, using the experimental model designed in the Institute of Experimental Pharmacology SAS. We would like to acknowledge PharmD., PhD. George Ballagi for his helpful technical advice in the introduction of use of devices from ADInstruments. The experiments were realized upon the financial support of grants VEGA 2/1068/15 and VEGA 1/1342/12.
